Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCM) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock.

Concord Medical Services Stock Up 0.4 %

NYSE:CCM opened at $3.93 on Monday. The company has a quick ratio of 0.46, a current ratio of 0.47 and a debt-to-equity ratio of 1.15. Concord Medical Services has a fifty-two week low of $3.80 and a fifty-two week high of $26.70. The firm’s fifty day simple moving average is $4.73 and its 200-day simple moving average is $5.43.

About Concord Medical Services

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.